SFX by Ex Libris Inc.

Title:	The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitors
Source:	Bioorganic & Medicinal Chemistry Letters [0960-894X] Steinman, Douglas yr:1998

Basic

Full text

Full text available via EZB-NALI5-00465 Elsevier Archive NL

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Thor, M. "Synthesis and pharmacological evaluation of a new class of peroxisome proliferator-activated receptor modulators." Bioorganic & medicinal chemistry letters 12.24 (2002): 3565-1982.
description	2.	SHINJI, C. "Design, synthesis, and evaluation of cyclic amide/imide-bearing hydroxamic acid derivatives as class-selective histone deacetylase (HDAC) inhibitors." Bioorganic & medicinal chemistry 14.22 (2006): 7625-7651.
description	3.	Dessallew, N. "QSAR study on piperidinecarboxamides as antiretroviral agents: An insight into the structural basis for HIV coreceptor antagonist activity." QSAR & combinatorial science 27.7 (2008): 901-912.
description	4.	Mor, M. "Synthesis and Quantitative Structure-Activity Relationship of Fatty Acid Amide Hydrolase Inhibitors: Modulation at the N-Portion of Biphenyl-3-yl Alkylcarbamates." Journal of medicinal chemistry 51.12 (2008): 3487-3498.
description	5.	Hajduk, Philip J. "SAR by NMR: putting the pieces together." Molecular interventions 6.5 (2006): 266-72.
description	6.	Charalambides, Yiannis C. "Comparison of Base‐Promoted and Self‐Catalyzed Conditions in the Synthesis of Isocyanates from Amines Using Triphosgene." Synthetic communications 37.4-6 (2007): 1037-1044.
description	7.	Su, Yuping i. "Discovery of a synthetic Aminopeptidase N inhibitor LB-4b as a potential anticancer agent." Bioorganic and medicinal chemistry letters 23.9 (2013): 2512-7.
description	8.	Tsuchida, H. "Gene expression of the p85alpha regulatory subunit of phosphatidylinositol 3-kinase in skeletal muscle from type 2 diabetic subjects." Pflügers Archiv 445.1 (2002): 25-31.
description	9.	Kopelovich, L. "Peroxisome proliferator-activated receptor modulators as potential chemopreventive agents. [Erratum to document cited in CA137:41177]." Molecular cancer therapeutics 1.7 (2002): 564-.
description	10.	Ebdrup, S. "Synthesis and Biological and Structural Characterization of the Dual-Acting Peroxisome Proliferator-Activated Receptor Î±/Î³ Agonist Ragaglitazar." Journal of medicinal chemistry 46.8 (2003): 1306-1317.
description	11.	Odedra, A. "Dicobaltoctacarbonyl-Mediated Synthesis of Tricyclic 5,6-Dihydropyran-2-one Derivatives via Tandem Cycloaddition Reaction between cis-Epoxyalkynes, a Tethered Olefin, and Carbon Monoxide." Journal of organic chemistry 72.2 (2007): 567-573.
description	12.	Basso, A. "Solid-phase synthesis of modified oligopeptides via Passerini multicomponent reaction." Tetrahedron Letters 44.11 (2003): 2367-3792.
description	13.	Shinji, C. "Design and synthesis of phthalimide-type histone deacetylase inhibitors." Bioorganic & medicinal chemistry letters 15.20 (2005): 4427-9.
description	14.	Tandon, Vishnu K. "Synthesis and evaluation of novel 1,4-naphthoquinone derivatives as antiviral, antifungal and anticancer agents." Bioorganic & medicinal chemistry letters 17.12 (2004): 2901-4574.
description	15.	Yu, Q. "Long-acting anticholinesterases for myasthenia gravis: synthesis and activities of quaternary phenylcarbamates of neostigmine, pyridostigmine and physostigmine." Bioorganic & medicinal chemistry 18.13 (2010): 4687-93.
description	16.	Patricelli, M. "Clarifying the catalytic roles of conserved residues in the amidase signature family." The Journal of biological chemistry 275.25 (2000): 19177-19184.
description	17.	Yu, R. "Total synthesis of indolizidine alkaloid (-)-209D: overriding substrate bias in the asymmetric rhodium-catalyzed [2+2+2] cycloaddition." Angewandte Chemie (International ed. in English) 48.13 (2009): 2379-2382.
description	18.	Breitenbucher, Amy G. "Novel ketooxazole based inhibitors of fatty acid amide hydrolase (FAAH)." Bioorganic & medicinal chemistry letters 18.6 (2007): 2109-13.
description	19.	Maeda, K. "Development of therapeutics for AIDS: Structure-based molecular targeting." Tuberculosis 87.Suppl. 1 (2007): 31-4.
description	20.	Hopkins, Andrew L L. "The druggable genome." Nature reviews. Drug discovery 1.9 (2002): 727-30.